iBio, Inc. (IBIO) vs Kalaris Therapeutics Inc (KLRS)
A side-by-side comparison of iBio, Inc. and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IBIO
iBio, Inc.
$1.05HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT
KLRS
Kalaris Therapeutics Inc
$2.90HealthcareDelayed quote: Oct 6, 2026, 11:38 AM EDT
Total return — IBIO vs KLRS
growth of $100 · dividends reinvested · last 10yIBIO -100.0% (-54.1%/yr)KLRS -99.1% (-37.3%/yr)KLRS compounded faster over this window
Log scale — wide-divergence pair
IBIO KLRS
IBIO vs KLRS: by the numbers
- •IBIO is the larger company ($67M vs $63M market cap).
- •Both run net losses; KLRS's is the smaller (0.00% vs -33044.00% net margin).
Metrics side by side
Valuation
| Metric | IBIO | KLRS |
|---|---|---|
| P/S ratio | 672.01 | N/A |
| P/B ratio | 0.78 | 1.10 |
Profitability
| Metric | IBIO | KLRS |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -35141.00% | 0.00% |
| Net margin | -33044.00% | 0.00% |
| ROE | -38.55% | -76.75% |
| ROIC | -40.22% | -52.40% |
Growth (annualized)
| Metric | IBIO | KLRS |
|---|---|---|
| Revenue CAGR (5Y) | -46.91% | N/A |
| Total return CAGR (5Y) | -70.43% | -81.13% |
Frequently asked
- How have IBIO and KLRS total returns compared?
- Over the past 5 years, IBIO delivered -70.43% and KLRS delivered -81.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.